Cholesterol-sharing mechanism points to potential new target for pancreatic cancer treatment
Fox Chase Cancer Center researchers identified a potential therapeutic target for pancreatic cancer after showing that tumor growth can be slowed and immune suppression can be reduced in preclinical trials by blocking a particular protein, called anoctamin 6 (ANO6).
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
How does daylight saving time affect our health?
United Kingdom
-
Tailoring prostate cancer radiotherapy to body clock could cut long-term side effects
United Kingdom
-
A new framework for safe, patient-centered prescribing of obesity medications in older adults
United Kingdom
-
The two most interesting risks to Anthropic United States
-
Nursing decisions to navigate when dying patients become unresponsive
United Kingdom
-
Gut microbial catalog reveals systemic inflammation drivers in spinal injury
United Kingdom
-
Platelet hyperactivity drives glioblastoma progression and deep vein thrombosis
United Kingdom
-
Study reveals immune rheostat maintaining skin barrier homeostasis
United Kingdom